Retractable Technologies's quarterly market cap
declined
from Sep. 2025 ($25.21 Mil) to Dec. 2025 ($23.11 Mil) and
declined
from Dec. 2025 ($23.11 Mil) to Mar. 2026 ($19.80 Mil).
Retractable Technologies's annual market cap
declined
from Dec. 2023 ($33.23 Mil) to Dec. 2024 ($20.61 Mil) but then
increased
from Dec. 2024 ($20.61 Mil) to Dec. 2025 ($23.11 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Retractable Technologies's Enterprise Value for Today is $-12.92 Mil.
Retractable Technologies (AMEX:RVP) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Retractable Technologies Market Cap Related Terms
Retractable Technologies Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Retractable Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Retractable Technologies Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's Market Cap distribution charts can be found below:
* The bar in red indicates where Retractable Technologies's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Retractable Technologies's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Retractable Technologies (RVP) has a Market Cap of $21.56 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Retractable Technologies and its competitors. According to the industry distribution chart, Retractable Technologies ranks #658 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 76%.
Is Retractable Technologies' Market Cap too high?
Retractable Technologies' current Market Cap is $21.56 Mil. The Medical Devices & Instruments industry median Market Cap is 122.56. Retractable Technologies' value of $21.56 Mil is 82.4% below this industry median. Based on the distribution chart, Retractable Technologies ranks #658 out of 866 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Retractable Technologies has a GF Score™ of 37/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Retractable Technologies' Market Cap compare to ZJYL and FEMY?
According to the Medical Devices & Instruments industry distribution chart, Retractable Technologies ranks #658 out of 866 companies for Market Cap. This places Retractable Technologies in the lower half of its industry. The industry median Market Cap is 122.56. Retractable Technologies' value of $21.56 Mil is 82.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.56, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Retractable Technologies's current Market Cap of $21.56 Mil is 82.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Retractable Technologies and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Retractable Technologies's current Market Cap is $21.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Retractable Technologies stock overvalued right now?
Based on GuruFocus' analysis, Retractable Technologies (RVP) is currently considered Fairly Valued. The stock's GF Value™ is $0.77, compared to a current price of $0.72 — trading 6.5% below its estimated fair value. The current Market Cap is $21.56 Mil and 82.4% below the Medical Devices & Instruments industry median of 122.56. Retractable Technologies' overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Retractable Technologies (RVP), the current Market Cap is $21.56 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Retractable Technologies (RVP) Overvalued in 2026?
Based on GuruFocus' analysis, Retractable Technologies stock appears to be undervalued.
The current stock price of $0.72 is trading 6.5% below its estimated GF Value™ of $0.77.
GuruFocus considers Retractable Technologies to be Fairly Valued.
Key valuation signals for RVP:
Market Cap: $21.56 Mil
GF Value™: $0.77 vs. price of $0.72 (6.5% below fair value)
Industry Position: 82.4% below the Medical Devices & Instruments median (#658 of 866)
No single metric tells the full story. See the RVP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.
37GF Score
Get the complete analysis for RVP
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RVP has been successfully added to your 
